je.st
news
Tag: osteoporosis
Merck and Premier Inc. Collaborate to Prevent Fractures for Osteoporosis Patients
2016-06-30 14:30:58| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. and CHARLOTTE, N.C. Companies working alongside providers to develop solutions to serious public health needs KENILWORTH, N.J. and CHARLOTTE, N.C. -- Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, have agreed to collaborate on the co-development of solutions to help improve population health. Initially, the companies will focus on reducing fracture rates for at-risk osteoporosis patients. Language: English read more
Tags: premier
prevent
patients
collaborate
Experimental osteoporosis drug bests Lilly's Forteo in study
2015-09-02 18:26:08| Agriculture - Topix.net
Amgen Inc. and Belgian partner UCB SA said an experimental osteoporosis drug designed to promote new bone growth helped mend older women's hip bone density in an advanced clinical test, sending UCB's stock to the highest level in more than five years.
Tags: study
drug
experimental
osteoporosis
Experimental osteoporosis drug bests Lilly's Forteo in study
2015-09-02 16:00:07| Food - Topix.net
Amgen Inc. and Belgian partner UCB SA said an experimental osteoporosis drug designed to promote new bone growth helped mend older women's hip bone density in an advanced clinical test, sending UCB's stock to the highest level in more than five years.
Tags: study
drug
experimental
osteoporosis
AHVLA Report: Neonatal Diarrhoea, Osteoporosis and Inclusion Body Rhinitis in UK Pigs
2015-08-03 02:00:00| ThePigSite - Industry News
UK - The Animal Health Veterinary Laboratories Agency (AHVLA) has looked into neonatal diarrhoea due to rotaviral and clostridial enteritis, inclusion body rhinitis with and without systemic involvement, multiple diagnoses of disease due to Streptococcus suis and osteoporosis leading to pathological fractures in weaned first-litter sows, according to its Pig Disease Surveillance Monthly Report for April 2015.
Tags: report
uk
body
inclusion
Microchips Biotech, Inc. Completes Development And Clinical Demonstration Of Proprietary Drug Delivery Platform And Advances Commercialization Efforts In Diabetes, Contraception And Osteoporosis
2014-12-29 01:32:30| drugdiscoveryonline Home Page
Microchips Biotech, Inc., formerly MicroCHIPS, Inc., recently announced the completion of the development and clinical demonstration of its proprietary drug delivery technology, a microchip-based implant capable of storing and releasing precise doses of a drug on-demand or at scheduled intervals for up to 16 years
Tags: and
development
delivery
efforts